FI945164A0 - Biologisesti aktiivisesti ureidojohdannaiset, jotka ovat käyttökelpoisia antimetastaattisina aineina - Google Patents
Biologisesti aktiivisesti ureidojohdannaiset, jotka ovat käyttökelpoisia antimetastaattisina aineinaInfo
- Publication number
- FI945164A0 FI945164A0 FI945164A FI945164A FI945164A0 FI 945164 A0 FI945164 A0 FI 945164A0 FI 945164 A FI945164 A FI 945164A FI 945164 A FI945164 A FI 945164A FI 945164 A0 FI945164 A0 FI 945164A0
- Authority
- FI
- Finland
- Prior art keywords
- biologically active
- derivatives useful
- antimetastatic agents
- ureido derivatives
- active ureido
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939304589A GB9304589D0 (en) | 1993-03-05 | 1993-03-05 | Biologically active ureido derivatives useful as antimetastic agents |
| PCT/EP1994/000268 WO1994020095A1 (en) | 1993-03-05 | 1994-01-31 | Biologically active ureido derivatives useful as antimetastatic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI945164A7 FI945164A7 (fi) | 1994-11-02 |
| FI945164A0 true FI945164A0 (fi) | 1994-11-02 |
Family
ID=10731580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI945164A FI945164A0 (fi) | 1993-03-05 | 1994-11-02 | Biologisesti aktiivisesti ureidojohdannaiset, jotka ovat käyttökelpoisia antimetastaattisina aineina |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5534539A (OSRAM) |
| EP (1) | EP0639073A1 (OSRAM) |
| JP (1) | JPH07506594A (OSRAM) |
| KR (1) | KR950701217A (OSRAM) |
| CN (1) | CN1103533A (OSRAM) |
| AU (1) | AU669269B2 (OSRAM) |
| CA (1) | CA2134098A1 (OSRAM) |
| FI (1) | FI945164A0 (OSRAM) |
| GB (1) | GB9304589D0 (OSRAM) |
| HU (1) | HUT71400A (OSRAM) |
| IL (1) | IL108665A (OSRAM) |
| MY (1) | MY110004A (OSRAM) |
| NZ (1) | NZ261308A (OSRAM) |
| PL (1) | PL305981A1 (OSRAM) |
| TW (1) | TW262465B (OSRAM) |
| WO (1) | WO1994020095A1 (OSRAM) |
| ZA (1) | ZA941126B (OSRAM) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9403909D0 (en) * | 1994-03-01 | 1994-04-20 | Erba Carlo Spa | Ureido derivatives of naphthalenephosphonic acids and process for their preparation |
| GB9504065D0 (en) * | 1995-03-01 | 1995-04-19 | Pharmacia Spa | Poly-pyrrolecarboxamidonaphthalenic acid derivatives |
| GB9602721D0 (en) * | 1996-02-09 | 1996-04-10 | Pharmacia Spa | Biologically active ureido derivatives useful in the treatment of multiple sclerosis |
| WO1999027939A1 (en) | 1997-12-04 | 1999-06-10 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Ureido derivatives of poly-4-amino-2-carboxy-1-methyl pyrrole compounds for inhibition of inflammation |
| GB9727524D0 (en) | 1997-12-31 | 1998-02-25 | Pharmacia & Upjohn Spa | Synergistic antitumor composition containing a biologically active ureido compound |
| WO1999058126A1 (en) * | 1998-05-11 | 1999-11-18 | The Endowment For Research In Human Biology, Inc. | Use of neomycin for treating angiogenesis-related diseases |
| ATE435202T1 (de) * | 2002-01-11 | 2009-07-15 | Daiichi Sankyo Co Ltd | Aminoalkoholderivat oder phosphonsäurederivat und diese enthaltende medizinische zusammensetzung |
| CN1921847B (zh) | 2004-02-24 | 2010-06-16 | 三共株式会社 | 氨基醇化合物 |
| EP3381897A1 (en) | 2017-03-27 | 2018-10-03 | Leadiant Biosciences SA | Derivatives of the disodium 2,2'-{carbonylbis[imino-3,1-phenylenecarbonylimino(1-methyl-1h-pyrrole-4,2-diyl)carbonylimino]}dinaphthalene-1,5-disulfonate salt and related compounds as heparanase inhibitors for the treatment of cancer |
| CN107235866B (zh) * | 2017-06-13 | 2019-09-10 | 重庆医科大学 | 一种用于检测次磺酸化蛋白质的荧光探针、制备方法及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5012285A (en) * | 1984-10-12 | 1986-05-02 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Use of suramin for clinical treatment of infection with any of the members of the family of human t-cell leukemia (htlv) viruses including lymphadenopathy virus (lav) |
| CA1308516C (en) * | 1987-07-06 | 1992-10-06 | J. William Lown | Oligopeptide anticancer and antiviral agents |
| GB9000644D0 (en) * | 1990-01-11 | 1990-03-14 | Erba Carlo Spa | New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds |
| GB9024738D0 (en) * | 1990-11-14 | 1991-01-02 | Erba Carlo Spa | A new method of treatment of tumor necroisis factor(tnf)-related diseases |
| GB9116896D0 (en) * | 1991-08-06 | 1991-09-18 | Erba Carlo Spa | 3-deoxymannosamine derivatives and process for their preparation |
| GB9216962D0 (en) * | 1992-08-11 | 1992-09-23 | Erba Carlo Spa | Therapeutically active naphthalenesulfonic-pyrrolecarboxamido derivatives |
-
1993
- 1993-03-05 GB GB939304589A patent/GB9304589D0/en active Pending
-
1994
- 1994-01-31 PL PL94305981A patent/PL305981A1/xx unknown
- 1994-01-31 AU AU60003/94A patent/AU669269B2/en not_active Ceased
- 1994-01-31 NZ NZ261308A patent/NZ261308A/en unknown
- 1994-01-31 HU HU9403177A patent/HUT71400A/hu unknown
- 1994-01-31 CN CN94190108A patent/CN1103533A/zh active Pending
- 1994-01-31 JP JP6519502A patent/JPH07506594A/ja active Pending
- 1994-01-31 CA CA002134098A patent/CA2134098A1/en not_active Abandoned
- 1994-01-31 EP EP94906181A patent/EP0639073A1/en not_active Ceased
- 1994-01-31 KR KR1019940703947A patent/KR950701217A/ko not_active Withdrawn
- 1994-01-31 WO PCT/EP1994/000268 patent/WO1994020095A1/en not_active Ceased
- 1994-02-16 IL IL108665A patent/IL108665A/xx not_active IP Right Cessation
- 1994-02-18 ZA ZA941126A patent/ZA941126B/xx unknown
- 1994-03-03 MY MYPI94000512A patent/MY110004A/en unknown
- 1994-03-04 TW TW083101900A patent/TW262465B/zh active
- 1994-11-02 FI FI945164A patent/FI945164A0/fi unknown
-
1995
- 1995-06-12 US US08/489,621 patent/US5534539A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| TW262465B (OSRAM) | 1995-11-11 |
| PL305981A1 (en) | 1995-02-20 |
| GB9304589D0 (en) | 1993-04-21 |
| IL108665A (en) | 1997-03-18 |
| ZA941126B (en) | 1994-08-30 |
| US5534539A (en) | 1996-07-09 |
| AU669269B2 (en) | 1996-05-30 |
| JPH07506594A (ja) | 1995-07-20 |
| EP0639073A1 (en) | 1995-02-22 |
| IL108665A0 (en) | 1994-05-30 |
| MY110004A (en) | 1997-11-29 |
| AU6000394A (en) | 1994-09-26 |
| FI945164A7 (fi) | 1994-11-02 |
| CN1103533A (zh) | 1995-06-07 |
| HUT71400A (en) | 1995-11-28 |
| NZ261308A (en) | 1996-02-27 |
| KR950701217A (ko) | 1995-03-23 |
| CA2134098A1 (en) | 1994-09-15 |
| WO1994020095A1 (en) | 1994-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1930330T3 (da) | Pleuromutilinderivater som antimikrobielle midler | |
| KR970006279A (ko) | 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물 | |
| DK0869949T3 (da) | Benzoxaziner som antimikrobielle midler | |
| FI923072L (fi) | Maongstegsbindemedel foer anvaendning i elstomerbelaeggningar, mastixbelaeggningar, dikt- och taetningsmedel | |
| FI932200L (fi) | Foer hudrengoering avsedd mild toalettbit, som innehaoller foer huden milt/fuktgivande silikonhjaelpmedel | |
| NO307045B1 (no) | Fenyleddiksyrederivater som pesticider, sammensetninger inneholdende slike forbindelser samt mellomprodukter | |
| NO984106D0 (no) | Azolobenzazepin-derivater som neurologisk aktive midler | |
| NO20002217L (no) | Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler | |
| DK0857718T3 (da) | Endothelinantagonist | |
| FI931278L (fi) | Polymerer, som innehaoller sulfogrupper | |
| DE59402194D1 (de) | Fungizide Wirkstoffkombinationen | |
| DE59408221D1 (de) | Fungizide Wirkstoffkombinationen | |
| FI961437A0 (fi) | Vaikuttavan aineen luovuttava systeemi | |
| EP0671911A4 (en) | CARBOXYPEPTIDYL DERIVATIVES AS AN ANTIDEGENERATIVE ACTIVE SUBSTANCES. | |
| FI933424L (fi) | Peptidyl-4-amino-2,2-difluor-3-oxo-1,6-hexandisyraderivat som antiinflammatoriska medel | |
| FI935427L (fi) | Haorlaeggningsmedel och -kompositioner, som innehaoller hydrofoba polymerer foer laeggning av haor | |
| FI945164A0 (fi) | Biologisesti aktiivisesti ureidojohdannaiset, jotka ovat käyttökelpoisia antimetastaattisina aineina | |
| ITMI940506A0 (it) | Derivati chinzolilamminici attivi come alfa-antagonisti | |
| EP0640333A3 (en) | Aerosol formulation-promoting hair growth. | |
| FI946128A7 (fi) | Biologisesti aktiiviset yhdisteet | |
| FI916018L (fi) | 1,3-dioxolanderivat som kolesterol- saenkande medel. | |
| DK0763535T3 (da) | Piperidinylmethyloxazolidin-2-on-derivater, deres fremstilling og deres anvendelse som centralnervesystem-aktive forbindelser | |
| NO972905D0 (no) | Tienoksasinon-derivater anvendelige som antivirusmidler | |
| FI931159A7 (fi) | Dosaerosoler, som innehåller som aktivt ämne flezelastin och med detta relaterade strukturer | |
| NO974651D0 (no) | Biologisk aktive ureidoderivater som er nyttige i behandlingen av multippel sklerose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or assigment of application |
Owner name: PHARMACIA UPJOHN S.P.A. |